Abstract | Background: Objective: Design: Dyslipidemic and IR men (n = 36) were recruited for this double-blind, randomized, crossover, controlled trial. Subjects consumed, in a random order, a fully controlled diet rich in SFAs (SFAs: 13.4% of energy; ω-6 PUFAs: 4.0%) and a fully controlled diet rich in ω-6 PUFAs (SFAs: 6.0%; ω-6 PUFAs: 11.3%) for periods of 4 wk, separated by a 4-wk washout period. At the end of each diet, the in vivo kinetics of apoB-containing lipoproteins were measured and the intestinal expression of key genes involved in lipoprotein metabolism was quantified in duodenal biopsies taken from each participant. Results: The substitution of ω-6 PUFAs for SFAs had no impact on TRL apoB-48 fractional catabolic rate (Δ = -3.8%, P = 0.7) and production rate (Δ = +1.2%, P = 0.9), although it downregulated the intestinal expression of the microsomal triglyceride transfer protein (Δ = -18.4%, P = 0.006) and apoB (Δ = -16.6%, P = 0.005). The substitution of ω-6 PUFAs for SFAs decreased the LDL apoB-100 pool size (Δ = -7.8%; P = 0.005). This difference was attributed to a reduction in the LDL apoB-100 production rate after the substitution of ω-6 PUFAs for SFAs (Δ = -10.0%; P = 0.003). Conclusions: This study demonstrates that the substitution of dietary ω-6 PUFAs for SFAs decreases the production and number of LDL particles in men with dyslipidemia and IR. This trial was registered at clinicaltrials.gov as NCT01934543.
|
Authors | Jean-Philippe Drouin-Chartier, André J Tremblay, Marie-Claude Lépine, Valéry Lemelin, Benoît Lamarche, Patrick Couture |
Journal | The American journal of clinical nutrition
(Am J Clin Nutr)
Vol. 107
Issue 1
Pg. 26-34
(01 01 2018)
ISSN: 1938-3207 [Electronic] United States |
PMID | 29381796
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | © 2018 American Society for Nutrition. All rights reserved. |
Chemical References |
- Apolipoprotein B-100
- Apolipoprotein B-48
- Blood Glucose
- Dietary Carbohydrates
- Dietary Fats
- Dietary Proteins
- Fatty Acids
- Fatty Acids, Omega-6
- Insulin
- Triglycerides
- Cholesterol
- Aspartate Aminotransferases
- Alanine Transaminase
|
Topics |
- Adolescent
- Adult
- Aged
- Alanine Transaminase
(blood)
- Apolipoprotein B-100
(blood)
- Apolipoprotein B-48
(blood)
- Aspartate Aminotransferases
(blood)
- Blood Glucose
(metabolism)
- Cardiovascular Diseases
(prevention & control)
- Cholesterol
(blood)
- Cross-Over Studies
- Diet
- Dietary Carbohydrates
(administration & dosage)
- Dietary Fats
(administration & dosage)
- Dietary Proteins
(administration & dosage)
- Double-Blind Method
- Dyslipidemias
(blood, drug therapy)
- Fatty Acids
(administration & dosage)
- Fatty Acids, Omega-6
(administration & dosage)
- Humans
- Insulin
(blood)
- Insulin Resistance
- Male
- Middle Aged
- Sample Size
- Triglycerides
(blood)
- Young Adult
|